相关产品推荐更多 >

Influenza A H5N9 (A/chicken/Italy/22A/1998) Hemagglutinin Protein (HA1 Subunit) (His Tag)
¥4520
Coronavirus spike重组蛋白|Recombinant SARS-CoV-2 Spike S1+S2 mutant Protein (ECD, His Tag)
¥4500
Influenza A H1N1 (A/Idaho/01/2017) Neuraminidase / NA (His Tag)
¥5170
SARS-CoV-2 Spike S1+S2 (T19R, G142D, E156G, HR157-158 deletion, L452R, T478K, D614G, P681R, D950N) Protein (ECD, His Tag)
¥4500
新冠病毒Spike RBD (E484K)重组蛋白
¥4500
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
-20℃ to -80℃
- 保质期:
12个月
- 英文名:
Recombinant HCV-E1 (subtype 1b, strain HC-J4) Protein (His Tag)
- 库存:
99
- 供应商:
北京义翘神州科技股份有限公司
- 规格:
50.00 µg/100.00 µg
| 规格: | 50.00 µg | 产品价格: | ¥1270.0 |
|---|---|---|---|
| 规格: | 100.00 µg | 产品价格: | ¥4520.0 |
蛋白名称:HCV-E1蛋白, HCV-E1 protein
蛋白构建:A DNA sequence encoding the envelope glycoprotein E1 of Hepatitis C virus (subtype 1b, strain HC-J4) (AAC15725.1) (Tyr192-Ile340) was expressed with a polyhistidine tag at the N-terminus.
表达宿主:HEK293 Cells
蛋白纯度:> 95 % as determined by SDS-PAGE.
蛋白活性:0
蛋白内毒素:< 1.0 EU per μg of the protein as determined by the LAL method
预测N端:His
蛋白分子量:The recombinant envelope glycoprotein E1 of Hepatitis C virus (subtype 1b, strain HC-J4) consists 168 amino acids and predicts a molecular mass of 18.7 kDa.
蛋白NP号:AAC15725.1
蛋白氨基酸序列:Tyr192-Ile340
蛋白标签:N-His
蛋白保存条件:Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Construction of Recombinant Vaccinia Virus Expressing HCV Genes
amounts of viral protein needed for this sort of study; nor can the effects of known antiviral agents be assessed on the replication of HCV. Recently, some laboratories have reported preliminary evidence of HCV replication in cultured cells
Interaction of p53 with the Adenovirus E1B-55 kDa Protein
The E1B-55 kDa oncoprotein of adenovirus type 5 targets the tumor suppressor protein p53. This includes four distinct activities: (i ) biochemical interaction of E1B-55 kDa with p53; (ii ) inhibition of p53-induced transcription; (iii
Purification of E1 and E1-Like Enzymes
that has been adapted for the isolation of E1 paralogs. We describe the facile purification of active E1 from outdated human red blood cells in yields (2–4 nmol/U of blood) that make this an attractive alternative to expression of the proteolytically labile recombinant
技术资料暂无技术资料 索取技术资料





